In this episode, Patrick Leung, CTO at Faro Health, shares how Faro is using artificial intelligence to revolutionize clinical trial design, transforming a historically slow and costly process. Drawing on his experience at Google and Two Sigma, Patrick discusses why he joined Faro and how the company is fundamentally changing the way new therapies reach patients.
Key Highlights:
-
The urgent need to address inefficiencies in traditional trial planning.
-
How Faro’s AI-driven platform reduces planning time from months to hours.
-
Real-world examples of impact with top pharma innovators like Merck and Recursion.
-
A nuanced take on combining technological innovation with clinical and human insight.
📄 Referenced Study:
Springer Article on Clinical Trial Efficiency
